BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

733 related articles for article (PubMed ID: 15705257)

  • 1. HMG-CoA reductase inhibitors and coenzyme Q10.
    Nawarskas JJ
    Cardiol Rev; 2005; 13(2):76-9. PubMed ID: 15705257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Considerations for supplementing with coenzyme Q10 during statin therapy.
    Levy HB; Kohlhaas HK
    Ann Pharmacother; 2006 Feb; 40(2):290-4. PubMed ID: 16449543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ubiquinone (coenzyme Q10) on myopathy in statin users.
    Schaars CF; Stalenhoef AF
    Curr Opin Lipidol; 2008 Dec; 19(6):553-7. PubMed ID: 18957876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Statin drugs decrease the plasma level of coenzyme Q10 (ubiquinone) in the organism].
    Rákóczi K; Párdutz A; Vécsei L
    Ideggyogy Sz; 2007 Jul; 60(7-8):295-300. PubMed ID: 17713110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role of coenzyme Q10 in facilitating recovery from statin-induced rhabdomyolysis.
    Wang LW; Jabbour A; Hayward CS; Furlong TJ; Girgis L; Macdonald PS; Keogh AM
    Intern Med J; 2015 Apr; 45(4):451-3. PubMed ID: 25827512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coenzyme Q10 and statin-related myopathy.
    Drug Ther Bull; 2015 May; 53(5):54-6. PubMed ID: 25977402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coenzyme Q10 and statins: biochemical and clinical implications.
    Littarru GP; Langsjoen P
    Mitochondrion; 2007 Jun; 7 Suppl():S168-74. PubMed ID: 17482884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced mitochondrial coenzyme Q10 levels in HepG2 cells treated with high-dose simvastatin: a possible role in statin-induced hepatotoxicity?
    Tavintharan S; Ong CN; Jeyaseelan K; Sivakumar M; Lim SC; Sum CF
    Toxicol Appl Pharmacol; 2007 Sep; 223(2):173-9. PubMed ID: 17610923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of treatment with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on serum coenzyme Q10 in diabetic patients.
    Miyake Y; Shouzu A; Nishikawa M; Yonemoto T; Shimizu H; Omoto S; Hayakawa T; Inada M
    Arzneimittelforschung; 1999 Apr; 49(4):324-9. PubMed ID: 10337451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CoQ10 and L-carnitine for statin myalgia?
    DiNicolantonio JJ
    Expert Rev Cardiovasc Ther; 2012 Oct; 10(10):1329-33. PubMed ID: 23190071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary and secondary coenzyme Q10 deficiency: the role of therapeutic supplementation.
    Potgieter M; Pretorius E; Pepper MS
    Nutr Rev; 2013 Mar; 71(3):180-8. PubMed ID: 23452285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined statin/coenzyme Q10 as adjunctive treatment of chronic heart failure.
    Okello E; Jiang X; Mohamed S; Zhao Q; Wang T
    Med Hypotheses; 2009 Sep; 73(3):306-8. PubMed ID: 19409711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhabdomyolysis associated with hydroxymethylglutaryl-coenzyme A reductase inhibitors.
    Jamal SM; Eisenberg MJ; Christopoulos S
    Am Heart J; 2004 Jun; 147(6):956-65. PubMed ID: 15199341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin-induced lactic acidosis: a rare adverse reaction?
    Goli AK; Goli SA; Byrd RP; Roy TM
    Clin Pharmacol Ther; 2002 Oct; 72(4):461-4. PubMed ID: 12386648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of coenzyme q10 on myopathic symptoms in patients treated with statins.
    Caso G; Kelly P; McNurlan MA; Lawson WE
    Am J Cardiol; 2007 May; 99(10):1409-12. PubMed ID: 17493470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of HMG-CoA reductase inhibitors on coenzyme Q10: possible biochemical/clinical implications.
    Hargreaves IP; Duncan AJ; Heales SJ; Land JM
    Drug Saf; 2005; 28(8):659-76. PubMed ID: 16048353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coenzyme Q10: a therapy for hypertension and statin-induced myalgia?
    Wyman M; Leonard M; Morledge T
    Cleve Clin J Med; 2010 Jul; 77(7):435-42. PubMed ID: 20601617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coenzyme Q10 depletion: etiopathogenic or predisposing factor in statin associated myopathy?
    Chatzizisis YS; Vaklavas C; Giannoglou GD
    Am J Cardiol; 2008 Apr; 101(7):1071. PubMed ID: 18359340
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of atorvastatin on left ventricular diastolic function and ability of coenzyme Q10 to reverse that dysfunction.
    Silver MA; Langsjoen PH; Szabo S; Patil H; Zelinger A
    Am J Cardiol; 2004 Nov; 94(10):1306-10. PubMed ID: 15541254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coenzyme Q10 reverses mitochondrial dysfunction in atorvastatin-treated mice and increases exercise endurance.
    Muraki A; Miyashita K; Mitsuishi M; Tamaki M; Tanaka K; Itoh H
    J Appl Physiol (1985); 2012 Aug; 113(3):479-86. PubMed ID: 22653988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.